Gotham Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,185
Closed -$236K 1458
2023
Q3
$236K Sell
1,185
-2,520
-68% -$596K ﹤0.01% 1190
2023
Q2
$1.06M Sell
3,705
-7,855
-68% -$2.18M 0.02% 756
2023
Q1
$2.51M Sell
11,560
-162
-1% -$31.6K 0.06% 436
2022
Q4
$2.41M Sell
11,722
-4,093
-26% -$1.03M 0.07% 362
2022
Q3
$4.4M Buy
+15,815
New +$4.02M 0.13% 179
2022
Q2
Sell
-2,387
Closed -$495K 1274
2022
Q1
$495K Buy
+2,387
New +$394K 0.02% 811
2021
Q4
Sell
-1,579
Closed -$325K 1253
2021
Q3
$325K Sell
1,579
-2,081
-57% -$409K 0.01% 795
2021
Q2
$694K Buy
+3,660
New +$599K 0.03% 595

Other funds holding SWAV

Gotham Asset Management's SWAV Position: Q4 2023 in Review

Gotham Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 1,185 shares — an estimated $236K sold.

Gotham Asset Management first reported a position in SWAV in Q2 2021 and held it in 8 quarters. The position peaked at $4.4M in Q3 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Gotham Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Gotham Asset Management sold 1,185 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $236K.
  • Gotham Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Gotham Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $4.4M in Q3 2022.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.